Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1598 | 6577 | 35.7 | 66% |
Classes in level above (level 3) |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
1122 | 2742 | BRADYKININ//B 1 RECEPTOR//BRADYKININ B 1 RECEPTOR |
4008 | 1790 | FACTOR XII//FACTOR XI//FACTOR XI DEFICIENCY |
5575 | 1539 | KALLIKREIN//KALLISTATIN//RENAL KALLIKREIN KININ SYSTEM |
21055 | 374 | T KININOGEN//T KININ//M 5011 |
30807 | 132 | HUMAN URINARY KALLIDINOGENASE SK 827//HYPERTENS DIABET UNIT//MUSCLE METAB |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | BRADYKININ | Author keyword | 348 | 30% | 15% | 971 |
2 | FACTOR XII | Author keyword | 137 | 64% | 2% | 136 |
3 | B 1 RECEPTOR | Author keyword | 132 | 94% | 1% | 47 |
4 | FACTOR XI | Author keyword | 123 | 68% | 2% | 109 |
5 | KALLIKREIN KININ SYSTEM | Author keyword | 120 | 61% | 2% | 129 |
6 | KALLIKREIN | Author keyword | 120 | 40% | 4% | 236 |
7 | KININOGEN | Author keyword | 119 | 58% | 2% | 138 |
8 | BRADYKININ RECEPTORS | Author keyword | 113 | 81% | 1% | 68 |
9 | KININS | Author keyword | 111 | 50% | 2% | 158 |
10 | B 2 RECEPTOR | Author keyword | 110 | 81% | 1% | 67 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BRADYKININ | 348 | 30% | 15% | 971 | Search BRADYKININ | Search BRADYKININ |
2 | FACTOR XII | 137 | 64% | 2% | 136 | Search FACTOR+XII | Search FACTOR+XII |
3 | B 1 RECEPTOR | 132 | 94% | 1% | 47 | Search B+1+RECEPTOR | Search B+1+RECEPTOR |
4 | FACTOR XI | 123 | 68% | 2% | 109 | Search FACTOR+XI | Search FACTOR+XI |
5 | KALLIKREIN KININ SYSTEM | 120 | 61% | 2% | 129 | Search KALLIKREIN+KININ+SYSTEM | Search KALLIKREIN+KININ+SYSTEM |
6 | KALLIKREIN | 120 | 40% | 4% | 236 | Search KALLIKREIN | Search KALLIKREIN |
7 | KININOGEN | 119 | 58% | 2% | 138 | Search KININOGEN | Search KININOGEN |
8 | BRADYKININ RECEPTORS | 113 | 81% | 1% | 68 | Search BRADYKININ+RECEPTORS | Search BRADYKININ+RECEPTORS |
9 | KININS | 111 | 50% | 2% | 158 | Search KININS | Search KININS |
10 | B 2 RECEPTOR | 110 | 81% | 1% | 67 | Search B+2+RECEPTOR | Search B+2+RECEPTOR |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | KININS | 295 | 58% | 5% | 338 |
2 | KININ RECEPTORS | 272 | 85% | 2% | 141 |
3 | MOLECULAR WEIGHT KININOGEN | 243 | 50% | 5% | 354 |
4 | TISSUE KALLIKREIN | 224 | 62% | 4% | 234 |
5 | HOE 140 | 215 | 72% | 3% | 170 |
6 | URINARY KALLIKREIN | 190 | 71% | 2% | 152 |
7 | DES ARG9 BRADYKININ | 183 | 87% | 1% | 91 |
8 | B2 RECEPTOR | 155 | 85% | 1% | 81 |
9 | PREKALLIKREIN | 151 | 61% | 2% | 161 |
10 | B 2 RECEPTOR | 144 | 68% | 2% | 127 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IMMUNOPHARMACOLOGY | 20 | 12% | 2% | 159 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences | 2005 | 454 | 506 | 75% |
BIOREGULATION OF KININS - KALLIKREINS, KININOGENS, AND KININASES | 1992 | 1457 | 596 | 70% |
The B-1 receptors for kinins | 1998 | 418 | 212 | 82% |
Contact system: A vascular biology modulator with anticoagulant, Profibrinolytic, antiadhesive, and proinflammatory attributes | 1997 | 305 | 230 | 80% |
KININ B-1 RECEPTORS - A REVIEW | 1995 | 311 | 132 | 86% |
Kinin B-1 receptors: key G-protein-coupled receptors and their role in inflammatory and painful processes | 2004 | 140 | 162 | 82% |
The kallikrein-kinin system: Current and future pharmacological targets | 2005 | 210 | 294 | 55% |
Bradykinin receptors and their antagonists | 1998 | 169 | 69 | 91% |
BRADYKININ AND INFLAMMATORY PAIN | 1993 | 472 | 49 | 53% |
The role of kinin receptors in cancer and therapeutic opportunities | 2014 | 8 | 174 | 67% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SOL SHERRY THROMBOSIS | 38 | 29% | 1.7% | 112 |
2 | GRP PHARMACOCHIM RECEPTEURS | 11 | 78% | 0.1% | 7 |
3 | GRP PEPTIDE BIOCHEM | 6 | 80% | 0.1% | 4 |
4 | KENT HAEMOPHILIA | 6 | 42% | 0.2% | 11 |
5 | U388 | 6 | 26% | 0.3% | 19 |
6 | MOL BIOL PEPTIDE HORMONES GRP | 6 | 100% | 0.1% | 4 |
7 | UROL CHIYODA KU | 6 | 100% | 0.1% | 4 |
8 | AMALIA BIRON THROMBOSIS HEMOSTASIS | 5 | 25% | 0.3% | 17 |
9 | ESCUELA MED ODONTOL | 4 | 75% | 0.0% | 3 |
10 | PULM CRIT CARE ASTHMA ALLERGY | 4 | 75% | 0.0% | 3 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000019978 | HEREDITARY ANGIOEDEMA//C1 INHIBITOR//ANGIOEDEMA |
2 | 0.0000009379 | PROTEIN C//ACTIVATED PROTEIN C//TISSUE FACTOR |
3 | 0.0000009130 | ANGIOTENSIN II//ANGIOTENSIN 1 7//RENIN ANGIOTENSIN SYSTEM |
4 | 0.0000008469 | CD26//PROLYL OLIGOPEPTIDASE//PROLIDASE |
5 | 0.0000007358 | BOWMAN BIRK INHIBITOR//PROTEASE ACTIVATED RECEPTOR//CYCLOTIDES |
6 | 0.0000004633 | CARDIOPULMONARY BYPASS//APROTININ//PERFUSION-UK |
7 | 0.0000004624 | UROKINASE RECEPTOR//FIBRINOLYSIS//PAI 1 |
8 | 0.0000004518 | ELAFIN//SLPI//SECRETORY LEUKOCYTE PROTEASE INHIBITOR |
9 | 0.0000004378 | TUBULOGLOMERULAR FEEDBACK//SALT SENSITIVITY//AFFERENT ARTERIOLE |
10 | 0.0000004359 | CATHEPSIN B//CATHEPSIN K//CATHEPSIN D |